Literature DB >> 10718938

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections.

P Mathurin1, V Thibault, K Kadidja, N Ganne-Carrié, J Moussalli, M El Younsi, V Di Martino, F Lunel, F Charlotte, M Vidaud, P Opolon, T Poynard.   

Abstract

In patients with multiple hepatotropic viral infections (B and C, or B, C and D), the reciprocal influence of each virus remains controversial. The aims of this study were twofold: first, to determine the impact of multiple infection on the replication status of B, C and D viruses and on histological features; and second, to compare patients with multiple infection to patients infected only with the hepatitis C virus (HCV). We retrospectively included 50 patients with multiple infection and 50 control HCV patients, who were matched on independent factors associated with fibrosis, such as age, gender, alcohol consumption and duration of infection. The replication status of hepatitis B virus (HBV), HCV and hepatitis D virus (HDV), and histological lesions, were determined. In patients with multiple infection, HCV RNA was present less frequently (44% vs 98%, P < 0.001) and the prevalence of cirrhosis was higher (35% vs 8%, P < 0.001). Among patients with triple infection (n = 16), HBV replication was observed in 25%, HCV RNA was detectable in only two (P < 0.0001) and HCV viremia was significantly lower than in the matched HCV patients (0 vs 54.7, P < 0.0001). Among patients with dual infection (n = 34), HCV RNA was present less frequently in those with serological markers of active HBV infection than in those without (30% vs 79%, P = 0.01). Hence, multiple infection is associated with a decrease of HCV replication. Cirrhosis seems to be more frequently observed in patients with multiple infection. In patients with triple infection, serum HCV RNA and markers of HBV replication were absent in 80%, suggesting that HDV acts as a dominant virus. In patients with dual infection, HBV and HCV exert an alternative, dominant replication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718938     DOI: 10.1046/j.1365-2893.2000.00195.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  14 in total

Review 1.  Hepatitis delta virus: A fascinating and neglected pathogen.

Authors:  Celso Cunha; João Paulo Tavanez; Severin Gudima
Journal:  World J Virol       Date:  2015-11-12

2.  Clearance of chronic HCV infection during acute delta hepatitis.

Authors:  K Deterding; S V Pothakamuri; V Schlaphoff; J Hadem; F Metzler; M J Bahr; M P Manns; M Cornberg; H Wedemeyer
Journal:  Infection       Date:  2007-12-14       Impact factor: 3.553

Review 3.  Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Authors:  Nicole D Ferrante; Vincent Lo Re
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

4.  Hepatitis D Virus: A Call to Screening.

Authors:  Joseph Ahn; Robert G Gish
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

5.  The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.

Authors:  F-C Tseng; B R Edlin; M Zhang; A Kral; M P Busch; B A Ortiz-Conde; T M Welzel; T R O'Brien
Journal:  J Viral Hepat       Date:  2008-05-27       Impact factor: 3.728

6.  Characterization of hepatitis delta virus in sub-Saharan Africa.

Authors:  Iris E Andernach; Lukas V Leiss; Zekiba S Tarnagda; Marc C Tahita; Jesse A Otegbayo; Joseph C Forbi; Sunday Omilabu; Ionela Gouandjika-Vasilache; Narcisse P Komas; Okwen P Mbah; Claude P Muller
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

Review 7.  Pathogenesis of and New Therapies for Hepatitis D.

Authors:  Christopher Koh; Theo Heller; Jeffrey S Glenn
Journal:  Gastroenterology       Date:  2018-10-18       Impact factor: 22.682

8.  Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection.

Authors:  N Coppola; A Marrone; M Pisaturo; M Starace; G Signoriello; I Gentile; L E Adinolfi; E Sagnelli; R Zampino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-01       Impact factor: 3.267

9.  Development of mathematical models for the analysis of hepatitis delta virus viral dynamics.

Authors:  Bruno C de Sousa; Celso Cunha
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

Review 10.  An overview of triple infection with hepatitis B, C and D viruses.

Authors:  Mehwish Riaz; Muhamad Idrees; Hifza Kanwal; Firoz Kabir
Journal:  Virol J       Date:  2011-07-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.